Press Releases

Benesch and OMNIVISION Secure Total Surrender from VisionX Technologies

November 21, 2024

Benesch is pleased to announce that, capping a series of four consecutive and total victories against meritless patent infringement claims, Benesch and OMNIVISION reported a stipulated judgment of non-infringement in a case filed by VisionX Technologies LLC. The prior victories came against Bell Semiconductor, LLC in 2023, Image Sensing LLC in 2022, and Cedar Lane Technologies in 2020.

VisionX sued OMNIVISION in November 2023, accusing OMNIVISION’s industry leading CMOS image sensors of infringing three patents that VisionX purchased in 2022. Led by Benesch partner David Bluestone, OMNIVISION’s litigation team pursued an aggressive defense from the beginning, maintaining that VisionX’s claims were meritless and crafted only to extract payment to avoid litigation. OMNIVISION refused to play VisionX’s game and steadfastly defended on the merits. With a claim construction hearing approaching, and facing potential sanctions for asserting meritless infringement claims, VisionX agreed to a stipulated judgment of non-infringement.

OMNIVISION has an unwavering policy against paying to settle meritless infringement claims. David has led OMNIVISION’s defense teams to all four victories, including cases in the International Trade Commission and the U.S. District Courts for the District of Delaware and the Central District of California.* OMNIVISION General Counsel Robert Cleary, who drives the company’s policy, praised David as a “meritless NPE’s nightmare.”

Robert elaborated on David and the Benesch team behind this latest victory, explaining, “Some NPEs thrive by putting forth complicated-looking nonsense, but David has the ability to masterfully understand complex tech and communicate the reality to the court. When faced with questionable litigation tactics in response, David is perfectly aggressive without losing credibility.” He added, “Over and over again, the result is victory for OMNIVISION. David has amassed an exceptional supporting cast at Benesch at all levels, which I appreciate as a former patent litigator. The team deserves its growing reputation. For OMNIVISION, we haven’t paid a penny to an NPE in over five years, and that is largely due to the extraordinary partnership with David and his team.”

David said, “Robert and OMNIVISION have a strong and principled policy against paying to settle baseless infringement claims, and it has been a privilege to stand with them on that principle. The Benesch team worked hard for this victory, and we are proud of the results.”

One of several new patent litigators Benesch has added to its Chicago office this year, David has made an immediate impact. The OMNIVISION defense team also included Sam Ruggio, Charlie McMahon, and Jodi Baker, as well as Salil Bali of Stradling, Yocca, Carlson, & Rauth. Kal Shah, head of the growing Benesch Intellectual Property group, said, “We are growing this group into an IP litigation powerhouse. We were thrilled to announce earlier this year that David and Charlie had joined us, and this OMNIVISION victory shows why.”

For more information on the case, click here.


* Previous victories secured before David Bluestone joined Benesch.

Latest News

Press Releases 6.2.26

Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First

Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.

Press Releases 5.20.26

Daily Journal Names Benesch Partner Charan Brahma a 2026 Top Intellectual Property Lawyer

Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to the Daily Journal’s 2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.